Cordance Medical is developing a non-invasive cap that uses ultrasound and microbubbles to reversibly open up the blood-brain barrier directly at the site of diseased brain tissue. This enables real-time molecular characterization of neurological diseases via liquid biopsy that will be used to improve patient outcomes by informing therapy selection, improving drug delivery, and enabling precision medicine.